Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma
- PMID: 22016811
- PMCID: PMC3189962
- DOI: 10.1371/journal.pone.0026058
Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma
Abstract
Both OTX2 and MYC are important oncogenes in medulloblastoma, the most common malignant brain tumor in childhood. Much is known about MYC binding to promoter regions, but OTX2 binding is hardly investigated. We used ChIP-on-chip data to analyze the binding patterns of both transcription factors in D425 medulloblastoma cells. When combining the data for all promoter regions in the genome, OTX2 binding showed a remarkable bi-modal distribution pattern with peaks around -250 bp upstream and +650 bp downstream of the transcription start sites (TSSs). Indeed, 40.2% of all OTX2-bound TSSs had more than one significant OTX2-binding peak. This OTX2-binding pattern was very different from the TSS-centered single peak binding pattern observed for MYC and other known transcription factors. However, in individual promoter regions, OTX2 and MYC have a strong tendency to bind in proximity of each other. OTX2-binding sequences are depleted near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding. This contrasts to the enrichment of E-box sequences at TSSs. Both OTX2 and MYC binding independently correlated with higher gene expression. Interestingly, genes of promoter regions with multiple OTX2 binding as well as MYC binding showed the highest expression levels in D425 cells and in primary medulloblastomas. Genes within this class of promoter regions were enriched for medulloblastoma and stem cell specific genes. Our data suggest an important functional interaction between OTX2 and MYC in regulating gene expression in medulloblastoma.
Conflict of interest statement
Figures






Similar articles
-
Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.PLoS One. 2014 Sep 8;9(9):e107156. doi: 10.1371/journal.pone.0107156. eCollection 2014. PLoS One. 2014. PMID: 25198066 Free PMC article.
-
Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.Mol Cancer Res. 2010 Oct;8(10):1344-57. doi: 10.1158/1541-7786.MCR-09-0546. Epub 2010 Sep 13. Mol Cancer Res. 2010. PMID: 21047732
-
Modeling medulloblastoma in vivo and with human cerebellar organoids.Nat Commun. 2020 Jan 29;11(1):583. doi: 10.1038/s41467-019-13989-3. Nat Commun. 2020. PMID: 31996670 Free PMC article.
-
14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review.Am J Med Genet A. 2024 Jul;194(7):e63604. doi: 10.1002/ajmg.a.63604. Epub 2024 Mar 21. Am J Med Genet A. 2024. PMID: 38511879 Review.
-
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.Int J Mol Sci. 2016 Oct 19;17(10):1744. doi: 10.3390/ijms17101744. Int J Mol Sci. 2016. PMID: 27775567 Free PMC article. Review.
Cited by
-
The clinical implications of medulloblastoma subgroups.Nat Rev Neurol. 2012 May 8;8(6):340-51. doi: 10.1038/nrneurol.2012.78. Nat Rev Neurol. 2012. PMID: 22565209 Review.
-
Medulloblastoma genomics in the modern molecular era.Brain Pathol. 2020 May;30(3):679-690. doi: 10.1111/bpa.12804. Epub 2019 Dec 16. Brain Pathol. 2020. PMID: 31799776 Free PMC article. Review.
-
Pediatric brain tumor cell lines.J Cell Biochem. 2015 Feb;116(2):218-24. doi: 10.1002/jcb.24976. J Cell Biochem. 2015. PMID: 25211508 Free PMC article.
-
Combinatorial regulation of a Blimp1 (Prdm1) enhancer in the mouse retina.PLoS One. 2017 Aug 22;12(8):e0176905. doi: 10.1371/journal.pone.0176905. eCollection 2017. PLoS One. 2017. PMID: 28829770 Free PMC article.
-
Blimp1 (Prdm1) prevents re-specification of photoreceptors into retinal bipolar cells by restricting competence.Dev Biol. 2013 Dec 15;384(2):194-204. doi: 10.1016/j.ydbio.2013.10.006. Epub 2013 Oct 12. Dev Biol. 2013. PMID: 24125957 Free PMC article.
References
-
- de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol. 2006;65:176–186. - PubMed
-
- Michiels EM, Oussoren E, Van Groenigen M, Pauws E, Bossuyt PM, et al. Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics. 1999;1:83–91. - PubMed
-
- Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res. 2005;65:919–924. - PubMed
-
- Boon K, Eberhart CG, Riggins GJ. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res. 2005;65:703–707. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources